Meeting
2017 Genitourinary Cancers Symposium
Cost-effectiveness analysis of magnetic resonance imaging-ultrasound fusion biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer.
Authors
Matthew Ingham
Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Matthew Ingham , Matthew Mossanen , Ye Wang , Steven Lee Chang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 25)
DOI
10.1200/JCO.2017.35.6_suppl.25
Abstract #
25
Poster Bd #
B12
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Racial variation in the reliability of prostate cancer indicators in men undergoing subsequent prostate biopsy.
First Author: Robert Scott Libby
Poster
2023 ASCO Genitourinary Cancers Symposium
Is transrectal ultrasound or magnetic resonance imaging better at estimating prostatic volume for patients with prostate cancer?
First Author: Maxwell Sandberg
Poster
2023 ASCO Genitourinary Cancers Symposium
The natural progression of patients with an IsoPSA value and its predictive ability of clinically significant prostate cancer on biopsy.
First Author: Nour Abdallah
Poster
2021 Genitourinary Cancers Symposium
MRI-guided fusion biopsy of the prostate resection bed among post-radical prostatectomy patients with rising PSA.
First Author: Cheyenne Williams